Clinical Trial Update: Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating CM512 injection for chronic spontaneous urticaria is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• CM512

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Chronic Spontaneous Urticaria (CSU) | Phase 2 | Status: RECRUITING